Briya Launches AI Platform for Medical Research

Briya has introduced Briya AIRE, a clinical-grade AI platform designed to accelerate medical and epidemiological research, announced in a press release. Briya AIRE is engineered to transform months of manual data analysis into actionable insights within minutes, facilitating faster and more cost-effective discoveries in the biopharma and academic research sectors.

The platform acts as a virtual epidemiologist and data analyst, enabling researchers to design patient cohorts, test hypotheses, and identify data patterns that might otherwise be overlooked. It is currently being utilized by global academic medical centers, biopharma organizations, and research institutions across various disciplines.

Briya AIRE's advanced natural language processing capabilities allow it to accurately identify patients at risk of severe conditions, such as metabolic dysfunction-associated steatohepatitis (MASH), directly from unstructured clinical data. This feature enables earlier interventions for high-risk patients, potentially improving patient outcomes.

The platform is built on Briya's secure infrastructure, ensuring compliance with U.S. and European privacy standards, and is accessible via aire.briya.cloud or the Briya website.